← Back to Search

Dialectical behavioral therapy for Bipolar Disorder (DB2 Trial)

N/A
Waitlist Available
Led By Benjamin I Goldstein, MD, PhD
Research Sponsored by Sunnybrook Health Sciences Centre
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at the end of study completion (three years)
Awards & highlights

DB2 Trial Summary

This trial will study the long-term effects of Dialectical Behavior Therapy on adolescents with Borderline Personality Disorder, as well as the long-term effects of DBT training on study therapists' knowledge and performance.

Eligible Conditions
  • Bipolar Disorder

DB2 Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at the end of study completion (three years)
This trial's timeline: 3 weeks for screening, Varies for treatment, and at the end of study completion (three years) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Barriers and Facilitators Assessment Instrument (name of scale)
Change in affective lability using the Children's Affective Lability Scale (CALS)
Change in emotion regulation using the Difficulties in Emotion Regulation Scale (DERS)
+17 more

DB2 Trial Design

1Treatment groups
Experimental Treatment
Group I: Adolescents with bipolar disorderExperimental Treatment1 Intervention
25 adolescents aged 14 to 21 with bipolar disorder (type I, type II, not otherwise specified/nos) will be enrolled in the dialectical behavioral therapy intervention.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Dialectical behavioral therapy
2019
N/A
~40

Find a Location

Who is running the clinical trial?

Centre for Addiction and Mental HealthOTHER
356 Previous Clinical Trials
81,429 Total Patients Enrolled
14 Trials studying Bipolar Disorder
1,474 Patients Enrolled for Bipolar Disorder
Sunnybrook Health Sciences CentreLead Sponsor
656 Previous Clinical Trials
1,551,427 Total Patients Enrolled
11 Trials studying Bipolar Disorder
835 Patients Enrolled for Bipolar Disorder
University of PittsburghOTHER
1,720 Previous Clinical Trials
16,342,796 Total Patients Enrolled
27 Trials studying Bipolar Disorder
5,734 Patients Enrolled for Bipolar Disorder

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~3 spots leftby Apr 2025